The Change of Soluble Programmed Death Ligand 1 (sPD-L1) in Plasma of Small Cell Lung Cancer and Its Clinical Significance

Background soluble programmed death-ligand 1 (sPD-L1) expression in lung squamous cell carcinoma and lung adenocarcinoma is associated with disease progression, and sPD-L1 expression in small cell lung cancer (SCLC) may have similar manifestations and become a potential marker for treatment. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Feijie, Dong, Yongquan, Li, Qianjun, Wang, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816561/
https://www.ncbi.nlm.nih.gov/pubmed/35126639
http://dx.doi.org/10.1155/2022/8375349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816561/
https://www.ncbi.nlm.nih.gov/pubmed/35126639
http://dx.doi.org/10.1155/2022/8375349

Ejemplares similares